America Great Health
AAGH · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.36 | 0.00 | 0.00 |
| FCF Yield | -9.71% | -2.91% | -5.91% | -0.10% |
| EV / EBITDA | -11.42 | -65.37 | -5.62 | -1,376.48 |
| Quality | ||||
| ROIC | 29.63% | 24.08% | 218.52% | -43.11% |
| Gross Margin | 57.61% | 82.52% | -1,417.90% | 26.24% |
| Cash Conversion Ratio | 0.50 | 0.99 | 0.30 | 1.22 |
| Growth | ||||
| Revenue 3-Year CAGR | 41.21% | 1.45% | 167.39% | 580,453.38% |
| Free Cash Flow Growth | 22.79% | 46.73% | -337.75% | -764.31% |
| Safety | ||||
| Net Debt / EBITDA | -3.16 | -4.06 | -0.26 | -2.56 |
| Interest Coverage | -1.76 | -1.54 | -24.80 | -12.15 |
| Efficiency | ||||
| Inventory Turnover | 1.50 | 0.33 | 13.69 | 18.39 |
| Cash Conversion Cycle | -3,884.20 | -13,715.32 | -300.45 | -10.80 |